Literature DB >> 20174452

Dopamine transporter trafficking: rapid response on demand.

Rong Chen1, Cheryse A Furman, Margaret E Gnegy.   

Abstract

The dopamine transporter (DAT) is a primary determinant of the concentration of dopamine in the synapse and is involved in a number of psychiatric and neurological diseases. The transporter actively takes up its physiological substrate, dopamine, when it is on the surface of the plasmalemmal membrane, but the concentration of DAT in the membrane is highly regulated by substrate. Substrates initially, and very rapidly, recruit more DAT into the membrane for greater function, but continued presence of substrate downregulates the activity of DAT and even membrane DAT content. This biphasic regulation is orchestrated by numerous signal transduction mechanisms, including a palette of protein kinases. Understanding the mechanisms of rapid regulation of DAT could provide new therapeutic strategies to improve transporter function and modulate responses to its more notorious substrates, amphetamine and methamphetamine.

Entities:  

Year:  2010        PMID: 20174452      PMCID: PMC2822347          DOI: 10.2217/fnl.09.76

Source DB:  PubMed          Journal:  Future Neurol        ISSN: 1479-6708


  91 in total

1.  Repeated amphetamine couples norepinephrine transporter and calcium channel activities in PC12 cells.

Authors:  L Kantor; M Zhang; B Guptaroy; Y H Park; M E Gnegy
Journal:  J Pharmacol Exp Ther       Date:  2004-08-30       Impact factor: 4.030

2.  Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors.

Authors:  Agustin Zapata; Bronwyn Kivell; Yang Han; Jonathan A Javitch; Elizabeth A Bolan; David Kuraguntla; Vanaja Jaligam; Murat Oz; Lankupalle D Jayanthi; Devadoss J Samuvel; Sammanda Ramamoorthy; Toni S Shippenberg
Journal:  J Biol Chem       Date:  2007-10-08       Impact factor: 5.157

Review 3.  Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.

Authors:  C Mehler-Wex; P Riederer; M Gerlach
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

4.  Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution.

Authors:  B G Garcia; Y Wei; J A Moron; R Z Lin; J A Javitch; A Galli
Journal:  Mol Pharmacol       Date:  2005-03-28       Impact factor: 4.436

5.  Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.

Authors:  R T Malison; S E Best; C H van Dyck; E F McCance; E A Wallace; M Laruelle; R M Baldwin; J P Seibyl; L H Price; T R Kosten; R B Innis
Journal:  Am J Psychiatry       Date:  1998-06       Impact factor: 18.112

6.  Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization.

Authors:  Ekaterina Boudanova; Deanna M Navaroli; Zachary Stevens; Haley E Melikian
Journal:  Mol Cell Neurosci       Date:  2008-06-25       Impact factor: 4.314

7.  The role of N-glycosylation in function and surface trafficking of the human dopamine transporter.

Authors:  Li-Bin Li; Nianhang Chen; Sammanda Ramamoorthy; Limen Chi; Xiao-Nan Cui; Lijuan C Wang; Maarten E A Reith
Journal:  J Biol Chem       Date:  2004-03-15       Impact factor: 5.157

8.  PI 3-kinase regulation of dopamine uptake.

Authors:  Lucia Carvelli; José A Morón; Kristopher M Kahlig; Jasmine V Ferrer; Namita Sen; James D Lechleiter; L M Fredrik Leeb-Lundberg; Gerald Merrill; Eileen M Lafer; Lisa M Ballou; Toni S Shippenberg; Jonathan A Javitch; Richard Z Lin; Aurelio Galli
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

9.  Negative regulation of dopamine transporter endocytosis by membrane-proximal N-terminal residues.

Authors:  Tatiana Sorkina; Toni L Richards; Anjali Rao; Nancy R Zahniser; Alexander Sorkin
Journal:  J Neurosci       Date:  2009-02-04       Impact factor: 6.167

10.  Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine.

Authors:  Jason M Williams; W Anthony Owens; Gregory H Turner; Christine Saunders; Concetta Dipace; Randy D Blakely; Charles P France; John C Gore; Lynette C Daws; Malcolm J Avison; Aurelio Galli
Journal:  PLoS Biol       Date:  2007-10-16       Impact factor: 8.029

View more
  16 in total

Review 1.  Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.

Authors:  Thamara E Osinga; Thera P Links; Robin P F Dullaart; Karel Pacak; Anouk N A van der Horst-Schrivers; Michiel N Kerstens; Ido P Kema
Journal:  FASEB J       Date:  2017-03-06       Impact factor: 5.191

2.  Environmental enrichment enhances synaptic plasticity by internalization of striatal dopamine transporters.

Authors:  Myung-Sun Kim; Ji Hea Yu; Chul Hoon Kim; Jae Yong Choi; Jung Hwa Seo; Min-Young Lee; Chi Hoon Yi; Tae Hyun Choi; Young Hoon Ryu; Jong Eun Lee; Bae Hwan Lee; Hyongbum Kim; Sung-Rae Cho
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-02       Impact factor: 6.200

3.  The Dopamine Transporter Recycles via a Retromer-Dependent Postendocytic Mechanism: Tracking Studies Using a Novel Fluorophore-Coupling Approach.

Authors:  Sijia Wu; Rita R Fagan; Chayasith Uttamapinant; Lawrence M Lifshitz; Kevin E Fogarty; Alice Y Ting; Haley E Melikian
Journal:  J Neurosci       Date:  2017-08-28       Impact factor: 6.167

4.  Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.

Authors:  Dhananjay Sakrikar; Michelle S Mazei-Robison; Marc A Mergy; Nathan W Richtand; Qiao Han; Peter J Hamilton; Erica Bowton; Aurelio Galli; Jeremy Veenstra-Vanderweele; Michael Gill; Randy D Blakely
Journal:  J Neurosci       Date:  2012-04-18       Impact factor: 6.167

5.  Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization.

Authors:  Sarah B Robinson; J Andrew Hardaway; Shannon L Hardie; Jane Wright; Ryan M Glynn; Daniel P Bermingham; Qiao Han; Sarah M Sturgeon; Phyllis Freeman; Randy D Blakely
Journal:  Mol Cell Neurosci       Date:  2016-11-30       Impact factor: 4.314

6.  Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter.

Authors:  Rong Chen; Conor P Daining; Haiguo Sun; Rheaclare Fraser; Stephanie L Stokes; Michael Leitges; Margaret E Gnegy
Journal:  J Neurochem       Date:  2013-03-18       Impact factor: 5.372

7.  Serotonin synthesis, release and reuptake in terminals: a mathematical model.

Authors:  Janet Best; H Frederik Nijhout; Michael Reed
Journal:  Theor Biol Med Model       Date:  2010-08-19       Impact factor: 2.432

Review 8.  Mechanisms of dopamine transporter regulation in normal and disease states.

Authors:  Roxanne A Vaughan; James D Foster
Journal:  Trends Pharmacol Sci       Date:  2013-08-20       Impact factor: 14.819

9.  Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization.

Authors:  Obulakshmi Arapulisamy; Padmanabhan Mannangatti; Lankupalle D Jayanthi
Journal:  J Biol Chem       Date:  2013-08-26       Impact factor: 5.157

10.  Brain Region-Specific Trafficking of the Dopamine Transporter.

Authors:  Ethan R Block; Jacob Nuttle; Judith Joyce Balcita-Pedicino; John Caltagarone; Simon C Watkins; Susan R Sesack; Alexander Sorkin
Journal:  J Neurosci       Date:  2015-09-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.